Phillips-Medisize is expanding the capabilities of its 380,000 square foot Molex Little Rock facility to include a FDA registered manufacturing Center of Excellence for Connected Health and drug delivery devices.

The construction of purpose-built clean room suites, as well as FDA registration and ISO 13485 certification are scheduled to be completed for its first customer’s production beginning in Q2 2018. 

“This facility will also allow us to accommodate large programs requiring extensive assembly and molding operations, in clean room and other controlled environments, within a compressed timeframe. The facility will have a particular focus on mid- to high-volume diagnostics, medical device and drug delivery systems that integrate electronics and digital applications, and will provide us with the additional space needed to reach our growth objectives over the upcoming years,” remarked Matt Jennings, chief executive officer and president of Phillips-Medisize.

This will be the company’s sixth expansion in the past six years to support long-term growth of its medical contract manufacturing business. These investments demonstrate ongoing support for biopharmaceutical and device customers by providing design, development, and manufacturing solutions for both mechanical and connected devices across multiple geographies.